Clinical Research Resources & Offices

DF/HCC has one of the largest clinical research initiatives in the country, taking a unified approach to approving, activating, monitoring, and supporting the cancer-related clinical trials conducted at our member institutions. For more information, please take a moment to review the functions of each of the 3 distinct clinical research offices below, and continue on to the appropriate destination.

For your convenience there are many ways to find the Policies, Guidance, Forms, Templates, and Resources that you may be looking for. Expand the 'CRS Introduction' section for a walkthrough, or head to one of DF/HCC's three clinical research offices below.

CRS Introduction

View resources that may be helpful within the Clinical Research Support section of the DF/HCC website.

Getting Around

New to clinical research at DF/HCC, or need a refresher on where to find certain resources? View the New PI and Staff page for more information or for support.

Find Documents

Search all documents via the Document Library search engine or look up a document relating to the protocol lifecycle stage (creation, activation, close-out, etc.) that it pertains to.

Lookup Contact Information

View a complete list of contact information for each Clinical Research Office at DF/HCC.

Clinical Research Offices

Clinical Research at Dana-Farber/Harvard Cancer Center member institutions is facilitated by way of a unified clinical research effort across all member institutions. There are three offices responsible for coordinating this unified effort: The Clinical Trials Research Informatics Office (CTRIO), The Office of Data Quality (ODQ), and The Office for Human Research Studies (OHRS).

Although all documents are available in a centralized place via the Protocol Lifecycle, or the Document Library, support for specific clinical research areas, functions, or software used across the Cancer Center can be attained by visiting the corresponding office page. View the common functions for each office below.

Clinical Research News

  • June 12, 2018 – Office of Data Quality

    Frequently asked questions related to the updated RCO-204 Policy and DF/HCC's requirements on the review and receipt of INDSRs - Now Posted

  • May 30, 2018 – Office for Human Research Studies

    The use of the data and specimens by an outside collaborator must be described in the protocol and the research consent from signed by each participant. Study teams must also determine whether the outside collaborator is...

  • May 29, 2018 – Office for Human Research Studies

    DF/HCC research involving future use and sharing of data and specimens must be described in the protocol and the research consent form signed by each participant in order for data and/or specimens to be used for future...